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Background: Idiopathic granulomatous mastitis (IGM) is a rare inflammatory disease.
Because of it’s uncommon etiology and rareness, diagnosis and treatment is still a challenge. Owing to wide
spectrum of IGM it is difficult to standardize and optimize the treatment. The aim of this study was to report and
describe the clinical signs, radiological findings, management, clinical course and the recurrence rate of the patients
which were treated due to IGM.
Methods: In this retrospective review of patients diagnosed with IGM histopathologically between January 2006 and
December 2011, medical reports, ultrasonography (US) and mammograhy (MMG) findings, follow-up information and
recurrence were obtained from records.
Results: Painful, firm and ill defined mass was the symptom of all patients. While parenchymal heterogeneity, abscess
and mass were the findings of US, increased asymmetric density was the main finding of MMG. Wide local excision was
performed in 15 (62.5%) patients, incisional biopsy with abscess drainage was performed in 9 (37.5%) patients. Median
follow-up was 34.8 (range 10–66) months.
Conclusions: While the physical examination give rise to thought of breast carcinoma, the appearance of parenchymal
heterogeneity and abscess formation on US especially with enlarged axillary lymph nodes support the presence of an
inflammatory process. But these findings do not exclude carcinoma. Hereby, histopathologic confirmation is mandatory
to ensure that a malignancy is not missed.
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IGM was first described by Kessler and Wolloch in 1972
[1]. IGM is a rare inflammatory disease of the breast,
but it is important because of two reasons. First clinical
and radiological findings of IGM mimicks breast carcin-
oma and the differential diagnosis can only be confirmed
histopathologically. Second, it is difficult to treat IGM
especially if presented with fistula and abscess formation.
Because of it’s unclear etiology and rareness, diagnosis and
treatment is still a challenge [2]. An optimal treatment has
not been yet established, while medical therapy, wide local
excision and abscess drainage are currently the favored
treatment options for IGM [3]. The aim of this study was* Correspondence: gultenkiyak@yahoo.com
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unless otherwise stated.to report and describe the clinical signs, radiological find-
ings, management, clinical course and the recurrence ratio
of the patients which were treated due to IGM.Methods
We reviewed records of patients diagnosed with IGM
histopathologically between January 2006 and December
2011 in this retrospective study. The design of the study
has been approved by Yildirim Beyazit University Faculty
of Medicine ethics committee thus meets the standards
of the Declaration of Helsinki. Due to retrospective na-
ture of the study, the ethics committee did not require a
written consent from the participants.
Medical reports about the patient’s complaints, pres-
ence of pregnancy, number of pregnancies, use of con-
traceptives, follow-up informations and recurrence were
obtained from clinical records. All of the patientsd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Location of lesions in the breast
Location of lesions in the breast No. (%)
Periareolar region 7 (29.2)
Diffuse 7 (29.2)
Upper external quadran 5 (20.8)
Inferior external quadran 3 (12.5)
Upper internal quadran 1 (4.2)
Inferior internal quadran 1 (4.2)
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performed on all patients. A MMG was obtained from
patients older than 40 years. A magnetic resonance im-
aging (MRI) was performed in one patient.
Histopathological diagnosis was obtained from inci-
sional or wide local excisional biopsies. Wide local exci-
sion was performed for a minimum lesion-free radial
margin 5–10 mm. Incisional biopsy was obtained from
patients with abscess formation. After drainage of abscess,
incisional biopsy was performed from abscess cavity and
obtained at least four tissue samples. If there was fistula
formation to the skin, affected skin was excised too.
Inflammatory reaction with granulomas which com-
posed of epitheloid histiocytes, Langhans giant cells ac-
companied by lymphocytes, plasma cells and occasional
eosinophils centered on lobules was diagnosed with
IGM on histopathologic examination. All aspirates and
tissue samples were examined with hematoxylin-eosin
staining procedure as well as special stains for tubercu-
losis and fungal infection. Cultures for aerob bacteries
(streptococcus, staphylococcus, enterococcus, klebsiella,
pseudomonas, e. coli..), anaerob bacteries (clostridium, bac-
teroides..), were performed for the patients with abscess for-
mation. US and physical examination were performed
every month until resolution of lesions was confirmed.Table 2 US findings of patients with IGM
US findings No. (%)
Parenchymal heterogeneity 7 (29.1)
Irregular mass 7 (29.1)
Abscess formation 4 (16.6)
Irregular mass + heterogeneity 1 (4.2)
Abscess formation + heterogeneity 4 (16.6)
Abscess formation + heterogeneity + mass 1 (4.2)Results
24 patients diagnosed with IGM histopathologically and
had complete follow-up data has been evaluated and in-
cluded in the study. The mean age was 38.4 years ranged
from 28 to 60 years. 87.5% of patients (n = 21) were at
reproductive ages. All patients had children. None of the
patients had a history of oral contraseptive use and lac-
tacion in the last one year. Painful , firm and ill defined
mass was the symptom of all patients. Painful mass le-
sions were accompanied with skin changes such as ery-
thema and edema in 16 (66.6%) patients. The left breast
was affected in 13 (54.1%) patients, right breast in 9
(37.5%) patients and bilateral in 2 (8.3%) patients. The
lesions were located in upper external quadrant in 5
(20.8%) patients, in upper internal quadrant in 1 patient
(4.2%) in inferior internal quadrant in 1 patient (4,2%),
in inferior external quadrant in 3 (12.5%) patients, in
periareolar region in 7 patients (29.2%) and diffuse in-
volvement was seen in 7 patients (29.2%) (Table 1).
Parenchymal heterogeneity with no discrete mass had
been established in 7 patients (29.1%), irregular mass in 7
patients (29.1%), abscess formation in 4 patients (16.6%),
irregular mass with heterogeneity in 1 patient (4.2%), het-
erogeneity with abscess formation in 4 patients (16.6%),
heterogeneity, abscess formation and mass in 1 patient
(4.2%) on US (Table 2) (Figure 1). Associated enlarged ax-
illary lymph nodes were present in 14 (41.7%) patients.MMG was obtained from 7 patients. MMG detected
increased asymmetric density in 3 patients, asymmetric
density with skin thickening in 2 patients and asymmet-
ric density with skin thickening and nipple inversion in
2 patients.
MRI was performed in one patient which involvement
was diffuse and bilateral and resistant to the treatment
(Figure 2). MRI was needed for this patient to obtain
additional information.
Wide local excision was performed in 15 (62.5%) pa-
tients, incisional biopsy with abscess drainage was per-
formed in 9 (37.5%) patients. Each case demonstrated
the presence of epithelioid histiocytes, lymphocytes,
plasma cells, polymorphonuclear leukocytes and multi-
nucleated Langhans-type giant cells without caseous ne-
crosis. Serologic and bacterial tests were negative in all
patients. But, patients with abscess formation received
amoxcisilin 875 mg and clavulanic acid 125 mg.
Median follow-up was 34.8 (range 10–66) months.
Treatment with wide local excision could be successfully
performed in 15 patients. There was recurrence after
24 months in one patient in another quadrant of the breast
and treated with reexcision. The mean interval of reso-
lution in patients with abscess formation was 5.1 months
(range 3–10 months). In one patient which involvement
was diffuse and bilateral, the disease relapsed repeatedly
with an abscess formation. At first she was reluctant for
use of corticosteroid but obliged to receive because her
quality of life was very affected. We administrated cortico-
steroid with a dose of 16 mg prednisone twice a day but
could not continue because of glucose intolerance.
Figure 1 Transvers US scan shows cystic lesion with thickened
wall consistent with abscess formation.
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IGM, is a rare benign inflamatory breast disease mostly
seen in females at a reproductive age [3]. In our study,
all but three of patients were at retroductive age and all
patients were parous. Many agents, such as local irri-
tants, oral contraseptive pill, viruses, mycotic and para-
sitic infections, hyperprolactinemia, diabetes mellitus,
smoking, alfa 1 antitrypsin deficiency, otoimmunity have
been proposed to explain the etiology of IGM but never
proven [3-8].Figure 2 T2 weighted fat saturated image demonstrate an
irregular non-mass lesion in lower iner quadrant in left breast
showing high signal intensity. After administration of Gadalinium
based contrast agent (L kont T1) the lesion enchanced partly in type
I and in type II pattern heterogenously.IGM presents most commonly with a painful, firm, ten-
der, ill defined mass in the breast and unilateral [1,8]. The
lesions may be located in any quadran of the breast [8]. In
consequence of granulomatous inflammation, IGM can
cause skin thickness, sinus and abscess formation, axillary
lymphadenopathy and nipple retraction which may be clin-
ically mistaken for breast carcinoma [1,3,8]. All patients
were admitted with painful mass to our institution, 66.6%
of these accompanied with skin changes. The lesions were
located in any location but there were the tendency the
subareolar and diffuse involvement with percentage of
41.7%. Thus bilateral involvement is reported very rare
[6,8,9], there were two patients in our series with bilateral
and diffuse involvement. All masses were firm and ill de-
fined and enlarged axillary lymph nodes were present in 14
(41.7%) patients, but all of these enlarged nodes were estab-
lished reactive and not suspicious for malignancy on US.
US and MMG identified an irregular and ill defined mass
in the majority of patients. The information, obtained from
US and MMG is non-spesific and lack of specificity to diag-
nose IGM or to exclude breast carcinoma. Memiş et al. re-
ported the appearance of irregular hypoechoic mass lesions
and tubular hypoechoic areas connecting to the mass as
frequent sonographic features [10]. In other studies, par-
enchimal heterogeneity and areas of mixed echo pattern
have been reported [7]. Distinct from these lesions enlarged
axillary lymph nodes give rise to thought a locally advanced
breast carcinoma [7]. In our study, the most common US
findings were parenchimal heterogeneity, irregular hypoe-
choic mass and abscess formation. 41.7% of patients pre-
sented enlarged axillary lymph nodes, but these nodes did
not show malignant criteria such as cortical thickness (cut-
off 2.5 mm) and the absence of the fatty hilum [11] on US.
To our opinion, while physical examination give rise to
thought a locally advanced breast carcinoma, the appear-
ance of parenchimal heterogeneity and abscess formation
on US especially with enlarged reactive axillary lymph
nodes support the presence of an inflammatory granu-
lomatous process. But these findings are non-specific and
do not exclude carcinoma. Hereby, histologic confirmation
is mandatory to ensure that malignancy is not missed.
An ill defined mass, asimmetrically increased diffuse or
focal density without parenchimal distortion or microcal-
cification are the most common findings on MMG [7,12].
Concordant with previous report asymmetric density was
detected in our all patients.
According to some studies, MRI does not provide ad-
junct information for the differentiation of IGM from
carcinoma [7]. But Dursun et al. reported that the kin-
etic features are usually nonsuspicious and can be help-
ful in the differential diagnosis from carcinoma [12]. But
MRI does not play a role in the differential diagnosis be-
tween other inflammatory and granulomatous diseases
and IGM [1,8,12].
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spesific enough, faithful to diagnose IGM and cannot dif-
ferentiate IGM from carcinoma and other causes of
granulomatous and inflammatory lesions such as bacterial
mastitis, tuberculous mastitis, foreign body granulomas,
sarcoidosis and Wegener ‘s granulomatosis [8]. Since pyh-
sical examination and imaging modalities fail to diagnose
and differential diagnose, histopathologic diagnosis must
be performed. Histopathologic diagnosis can be achieved
with fine needle aspiration cytology (FNAC), core, inci-
sional or excisional biopsy [7]. But the usefulness and reli-
ability of FNAC has been debated, because some
authors informed the useful role of FNAC and the
others expressed that the various causes of granuloma-
tous inflammation cannot be differentiated with FNAC
[6,13,14]. In our patients, the histopathologic diagnosis
was obtained from excisional and incisional biopsies, we
have not prefferred FNAC.
The optimal treatment of IGM remains controversial.
Surgical excision stil seems to be the best treatment. Wide
local excision can be appropriate treatment also provide
exact diagnosis and treatment. After wide local excision, if
possible, further therapy is not needed. Different recurrence
rates (range 5.5%-50%) are reported after wide local exci-
sion [1,8]. There was one (6.6%) recurrence of 15 patients
that wide local exsicion was performed in our patients. Our
recurrence rate is lower than reported rates [11].
According to our opinion, there is no problem if wide
local excision can be performed. As a matter of fact,
complicated IGM with abscess, fistula or diffuse involve-
ment poses the problem. There is not ideal treatment
for complicated IGM. In these patients, wide local exci-
sion cannot be achieved. Lai et al.reported that spontan-
eous resolution occured in 50% of cases of IGM without
any treatment with a mean interval of 14.5 months [15].
Also, we had 9 patients which wide local exision could
not be performed because of abscess formation and/or
diffuse involvement. The lesions of the patients all but
one resolved with a mean interval of 5.1 months (range
3–10 months). In one patient which involvement was
diffuse and bilateral the disease relapsed repeatedly with
an abscess formation. There was not recurrence in the
other patients with abscess formation.
Some authors recommended to reduce the size for
complicated and resistant cases or diffuse lesions before
excision [1]. But there has been reluctance for side ef-
fects. We suggested steroid to our complicated patients
after abscess drainage and antibiotics, but any patient ac-
cepted by reason of side effects, they preffered conserva-
tive treatment with close follow-up.
We consider that wide local excision is the better
treatment of choice of IGM if possible. We hesitate to
recommend corticosteroids in complicated cases for sev-
eral reasons. First, there is no consensus about timing,duration and dose of corticosteroid administration. Second,
according to the study of Sakurai et al., complete resolution
of mass lesions with corticosteroid was achieved from 4 to
10 months [2]. Moreover spontaneous resolution occured
with a mean interval of 3.3 months in the patients with ab-
scess drainage in our study. But clinical presentation of pa-
tient population was different in above mentioned study
and in our series. Accordingly it is necessary to know if
corticosteroid is proven to rapidly resolve lesions than con-
servative approach. According to us it is important to keep
in mind that spontaneous resolution may occur rapidly
contrary to expectations. At least, we consider that corti-
costerod administration may be suspended after a short
follow-up period to see if spontaneous resolution is present
or not.
There is still not any commonly accepted optimal
treatment for IGM. Wide local excision and corticoster-
oid administration has been reported for the first line
treatment of IGM. The wide spectrum of clinical signs,
symptoms and course of IGM make it difficult to choose
and standardise a favorable treatment. Which one of the
treatment modalities should be favorable? When should
wide local excision or corticosteroid be preferred? Is it
true to administrate the same dose or duration of corti-
costeroids for any patient? What should be done if pa-
tient is reluctant to corticosteroid?
It is clear there is a need of prospective randomized
trials comparing conservative approach, wide local exci-
sion and corticosteroid administration to optimize and
standardize the diagnosis and treatment of IGM. Never-
theless, it may be possible to compose an algorithm
which is mandatory for treatment of IGM.
Conclusion
IGM is a rare benign inflammatory breast disease that
may be misdiagnosed as breat carcinoma. Because of
clinical and imaging diagnosis has often been difficult,
the definitive diagnose must be obtained from histo-
pathological diagnose.
There is still no commonly accepted treatment for
IGM. We consider that wide local excision is the better
treatment choice if possible. But, complicated IGM with
abcess, fistula and diffuse involvement poses the prob-
lem. In this study we observed that spontaneous reso-
lution may occur in these patients and recurrence is not
higher from other series.
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